Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study

Pirsch, 1997, A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation, Transplantation, 63, 977, 10.1097/00007890-199704150-00013

Mayer, 1997, Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group, Transplantation, 64, 436, 10.1097/00007890-199708150-00012

Knoll, 1999, Tacrolimus versus ciclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials, BMJ, 318, 1104, 10.1136/bmj.318.7191.1104

Kovarik, 1994, Cyclosporine pharmacokinetics and variability from a microemulsion formulation: a multicenter investigation in kidney transplant patients, Transplantation, 58, 658, 10.1097/00007890-199409000-00004

Kovarik, 1996, Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation, Transplantation, 62, 759, 10.1097/00007890-199609270-00010

1964, Recommendations guiding physicians in biomedical research involving human subjects

Solez, 1993, International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology, Kidney Int, 44, 411, 10.1038/ki.1993.259

Silkensen, 2000, Long-term complications in renal transplantation, J Am Soc Nephrol, 11, 582, 10.1681/ASN.V113582

Lindholm, 1993, The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplant patients treated by 3 cyclosporine regimens, Transplantation, 56, 307, 10.1097/00007890-199308000-00010

Basadonna, 1993, Early versus late acute renal allograft rejection: impact on chronic rejection, Transplantation, 55, 993, 10.1097/00007890-199305000-00007

Matas, 1994, The impact of an acute rejection episode on long-term renal allograft survival (t1/2), Transplantation, 57, 857, 10.1097/00007890-199403270-00015

Niese, 1995, A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months, Transplant Proc, 27, 1849

Nashan, 1997, Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients, Lancet, 350, 1193, 10.1016/S0140-6736(97)09278-7

Opelz, 1998, Association of chronic kidney graft failure with recipient blood pressure, Kidney Int, 53, 217, 10.1046/j.1523-1755.1998.00744.x

Peschke, 1999, Hypertension is associated with hyperlipidemia, coronary heart disease and chronic graft failure in kidney transplant recipients, Clin Nephrol, 51, 290

Kobashigawa, 1997, Hyperlipidemia in solid organ transplantation, Transplantation, 63, 331, 10.1097/00007890-199702150-00001

Dimény, 1995, Hyperlipidaemia in renal transplantation: risk factor for long-term graft outcome, Eur J Clin Invest, 25, 574, 10.1111/j.1365-2362.1995.tb01748.x

Fellström, 1999, The effects of lipids on graft outcome, Transplant Proc, 21, 14, 10.1016/S0041-1345(99)00786-1

Wissing, 2000, Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection, Transplantation, 70, 464, 10.1097/00007890-200008150-00012

Jensik, 1998, Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial, Transplant Proc, 30, 1216, 10.1016/S0041-1345(98)00216-4